Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-04-26Clinical Trial Update: The Effects of Raspberry Leaf Tea on Blood Glucose Control [NA]
A clinical trial is investigating whether raspberry leaf tea improves blood glucose control in adults with type 2 diabetes. The study is spo…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Effect of the Antidiabetic Drug Dapagliflozin on the Coronary Macrovascular and Microvascular Function in Type 2 Diabetic Patients [Phase 4]
A Phase 4 trial evaluating the antidiabetic drug dapagliflozin on coronary vascular function in patients with Type 2 diabetes has been termi…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Phase 1b/2a Study of GSBR-1290 in Adult Overweight or Obese Healthy Subjects and Subjects With Type 2 Diabetes Mellitus [Phase 1, Phase 2]
Phase 1b/2a study of GSBR-1290 in adults with obesity and Type 2 Diabetes Mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Respiratory Physiotherapy in Type 2 Diabetes and Bariatric Surgery [NA]
Clinical trial on respiratory physiotherapy for patients with Type 2 Diabetes and those considered bariatric surgery candidates has complete…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Effects of a Health Intervention on Hypoglycemic Coping : a Pilot Study [NA]
A completed pilot trial evaluating a health education intervention aimed at improving coping with hypoglycemia in people with Type 2 Diabete…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-04-22Clinical Trial Update: Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin. [Phase 4]
A decentralized N=1 trial evaluates individual response to dapagliflozin in type 2 diabetes patients, completed phase 4.
-
CLINICAL_TRIALS trial_result · 2024-04-17Clinical Trial Update: Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus (T2DM) Aged 10 to Below 18 Years Old [Phase 3]
Phase 3 pediatric trial evaluated the safety and efficacy of dapagliflozin in combination with saxagliptin in adolescents with Type 2 diabet…
-
CLINICAL_TRIALS trial_result · 2024-04-16Clinical Trial Update: GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes [Phase 4]
Phase 4 clinical trial update on a GLP-1 receptor agonist exploring effects on albuminuria in patients with type 2 diabetes; study terminate…
-
CLINICAL_TRIALS trial_result · 2024-04-16Clinical Trial Update: Vascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI. [Phase 4]
Phase 4 trial investigating whether adding carvedilolCR to ACE inhibitors provides vascular benefits in patients with type 2 diabetes and hy…
-
CLINICAL_TRIALS trial_result · 2024-04-16Clinical Trial Update: Virtual Diabetes Specialty Clinic: A Study Evaluating Remote Initiation of Continuous Glucose Monitoring [NA]
A completed clinical trial evaluating remote initiation of continuous glucose monitoring in a virtual diabetes specialty clinic; results pos…
-
CLINICAL_TRIALS trial_result · 2024-04-08Clinical Trial Update: A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight [Phase 3]
Phase 3 trial update for tirzepatide in adults with type 2 diabetes and overweight/obesity, completed with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-04-08Clinical Trial Update: Evaluating the Efficacy and Safety of Empagliflozin Addition to Insulin and Oral Antidiabetic Medication (OAD) Regimen in Poorly Controlled Type 2 Diabetes and Obese Patient [Phase 4]
Phase 4 trial investigating adding empagliflozin to insulin and oral antidiabetic therapy in poorly controlled type 2 diabetes with obesity;…
-
CLINICAL_TRIALS trial_result · 2024-04-08Clinical Trial Update: A Study to Investigate the Effect of DWP16001 as add-on Therapy to Drug A in Patients With Type 2 Diabetes Mellitus [Phase 3]
A Phase 3 clinical trial is examining DWP16001 as add-on therapy to Drug A for type 2 diabetes mellitus and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-04-08Clinical Trial Update: EndoBarrier in Obese Subjects With Type 2 Diabetes Mellitus [NA]
Clinical trial update for EndoBarrier in obese subjects with type 2 diabetes; the study has completed and results were posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-04-04Clinical Trial Update: The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin [Phase 3]
A Phase 3 clinical trial evaluating DWP16001 in combination with metformin for type 2 diabetes patients inadequately controlled on metformin…
-
CLINICAL_TRIALS trial_result · 2024-04-04Clinical Trial Update: Effects of Walking and Heating on Vascular Function in Diabetic Patients [NA]
A completed clinical trial exploring how walking and heating affect vascular function in adults with type 2 diabetes and obesity.
-
CLINICAL_TRIALS trial_result · 2024-04-03Clinical Trial Update: Research Study to Compare Three Doses of Semaglutide Tablets Taken Once Daily in People With Type 2 Diabetes [Phase 3]
A Phase 3 trial comparing three daily doses of oral semaglutide in adults with Type 2 diabetes has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: The Use of Icosapent Ethyl on Vascular Progenitor Cells in Individuals With Elevated Cardiovascular Risk [Phase 4]
A Phase 4 clinical trial evaluated the effect of icosapent ethyl on vascular progenitor cells in individuals with elevated cardiovascular ri…
-
CLINICAL_TRIALS trial_result · 2024-04-01Clinical Trial Update: Efficacy and Safety of Semaglutide Injection in Subjects With Type 2 Diabetes [Phase 3]
Phase 3 trial update on semaglutide injection for type 2 diabetes evaluating efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2024-03-29Clinical Trial Update: A Study of Oral Insulin to Reduce Liver Fat Content in Type 2 Diabetes Patients With Nonalcoholic Steatohepatitis (NASH) [Phase 2]
Phase 2 study evaluating oral insulin to reduce liver fat in type 2 diabetes patients with nonalcoholic steatohepatitis has completed with r…
-
FDA approval · 2024-03-29FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Metformin hydrochloride from Aurobindo Pharma Limited, making a generic version available.
-
CLINICAL_TRIALS trial_result · 2024-03-28Clinical Trial Update: Addressing Basic Needs to Improve Diabetes Outcomes in Medicaid Beneficiaries [Phase 2]
Phase 2 clinical trial investigating addressing basic needs to improve diabetes outcomes in Medicaid beneficiaries.
-
CLINICAL_TRIALS trial_result · 2024-03-26Clinical Trial Update: Efficacy and Safety of AJU-A51 in Type 2 Diabetes Mellitus Patients [Phase 3]
Phase 3 trial update for AJU-A51 in type 2 diabetes reports efficacy and safety findings.
-
CLINICAL_TRIALS trial_result · 2024-03-22Clinical Trial Update: Impact of Dapagliflozin as Add-on Therapy on Glycemic Status and Quality of Life in Type 2 Diabetic Patients [Phase 4]
Phase 4 trial update evaluating dapagliflozin as add-on therapy for glycemic status and quality of life in type 2 diabetes with diabetic nep…
-
CLINICAL_TRIALS trial_result · 2024-03-20Clinical Trial Update: Research Study to Compare a New Medicine "Fast-acting Insulin Aspart" to Another Medicine "Insulin Aspart" in Chinese People With Diabetes [Phase 3]
A Phase 3 trial comparing Fast-acting Insulin Aspart to Insulin Aspart in Chinese adults with Type 1 or Type 2 diabetes has completed, with …